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The diagnosis of catheter-related infections relies on the presence of clinical manifesta-
tions of infection and the evidence of colonization of the catheter tip by bacteria,
mycobacteria, or fungi. The reference method to confirm the latter requires the with-
drawal of the catheter for culturing, which frequently turns out to be inconvenient,
unnecessary and costly.
New methods try to avoid these drawbacks and to assess the presence of tip colonization
without withdrawal. Comparative quantitative blood cultures with a marked increase
(5) in colony counts between blood obtained from the catheter lumen and from a
peripheral vein simultaneously is one of those methods. It has a high sensitivity (>80%)
and specificity (94–100%) but it is cumbersome and requires both an easy backflow of
blood in the catheter and the existence of bacteremia. Cytocentrifugation and acridine
orange staining of blood withdrawn from an infected catheter lumen has a sensitivity and
a specificity of over 90% for the diagnosis of tip colonization.
‘Superficial cultures’ comprise the semiquantitative culture of the hub, of the skin
surrounding the catheter entrance and of the first subcutaneous portion (1 cm) of the
catheter after swabbing. The sensitivity of this method is >90%, specificity is >80%, and
positive and negative predictive values for catheters (considering together those with and
without clinical data of infection) are 66 and 97%, respectively.
Endoluminal brushing has proved to be an impractical and unreliable procedure, at least
in our experience.
New methods based on the speed of bacterial growth to detectable levels of micro-
organisms in conventional blood cultures are a new and interesting way of assessing
catheter-related infections. Moreover, as the use of antimicrobial-coated catheters
becomes more prevalent, the existing definitions of catheter colonization and catheter-
related infection may need to be modified, because such coatings may lead to false-
negative culture results.
Many catheter infections, diagnosed without catheter withdrawal, can be handled
nowadays with the so-called ‘antibiotic lock-in technique’, which consists in ‘locking’
the infected catheter lumen with a solution containing antibiotics. A high proportion of
infected catheters, mainly those with coagulase-negative staphylococci, can be main-
tained in place and sterilized with this technique, including catheters in patients with
therapeutic failure after receiving conventional intravenous antibiotic therapy.
New diagnostic and therapeutic techniques may avoid the unnecessary withdrawal of
thousands of efficient, difficult to replace and expensive intravascular lines.
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I N T R O D U C T I O N
Central venous catheters (CVC) are an integral
part of modern medical practice and their advan-
tages are beyond doubt.
More than 20 million (over 50%) of inpatients in
the USA receive intravenous therapy every year
[1–3] and almost 5 million require central venous
catheterization. This fact accounts for approxi-
mately 250 000 catheter-related infections (CRI)
and 120 000 episodes of catheter-related blood-
stream infection (CR-BSI) annually in the USA
[1–4].
Data from the NNIS system (US) between Jan-
uary 1992 and February 1998 showed that BSI is
the third most frequent nosocomial infection and
accounted for 14% of all nosocomial infections [5].
BSIs prolong hospital stays from 7 to 21 days and
account for an estimated increase in hospital costs
of $3000–40 000 per patient [6–9]. In addition, an
estimated 10–20% attributable mortality owing to
nosocomial CR-BSI has been reported [6].
In Europe, and according to the ESGNI-2 point
prevalence study, 71% of all patients with BSI had
an intravenous line [10]. BSI accounted for 13%
of all nosocomial infections in a Swiss 1-week
prevalence study conducted in 1996 and the use
of a CVC was an independent risk factor for
infection [odds ratio (OR) 3.3] [11]. In different
European studies, BSI related to catheter infection
accounts for 23.5–66% of all bacteremic episodes
[12–14]. The increased cost per survivor in inten-
sive care unit (ICU) patients with a BSI has been
estimated at $28 960, with a 25% mortality [7,15].
The incidence of CR-BSI should be calculated
per 1000-device-days (incidence density) rather
than as the number of infections per patient, to
be able to compare length of site use. Overall rates
vary according to type of device and its location
and typeof patient. The calculated rates are shown
in Table 1.
The risk of acquiring a CRI depends on the type
of patient, catheter location and type and policy for
catheter care. ICU patients pose a higher risk and
usually have multiple intravenous lines [16]. Pre-
vention is a key issue in order to control their asso-
ciated mortality and an increase of costs [16,17].
P A T H O G E N E S I S A N D E T I O L O G Y
Infection related to intravascular devices may
develop by five major mechanisms, of which the
Table 1 Calculated rates from published data for CR-BSI (rate of infection per 1000 catheter days, or incidence density) by
type of catheter and type of patient
Type of catheter Setting Median, ranges
Peripheral catheters (all types) Trauma ICU 2.0; N/A
Surgical ICU 0.5; N/A
Pediatric ICU 0.4; N/A
Peripheral venous catheters
(steel, Teflon1, heparin locks)
Med-surg ward (adult & pediatric) 0; 0–8.7
Peripheral arterial catheter ICU 0; 0–8.7
Central catheters CCU 3.6; 2.8–4.4
Med/surg ICU 4.1; 3.9–6.0
Neurosurgical ICU 4.9; N/A
Pediatric ICU 6.0; N/A
Surgical ICU 5.5; N/A
Trauma ICU 8.0; N/A
Burn ICU 30.2; N/A
Respiratory ICU 3.5; N/A
Neonatal ICU, birth weight <1500 g 14.6;< 5–60
Neonatal ICU, birth weight 1500 g 5.1;< 5–35
Peripherally inserted central catheters (PICC) 0.4; N/A
Cuffed catheters (Hickman, Broviac) Immunosuppressed patients 1.9; 0.6–6.6
Totally implantable devices Immunosuppressed patients 0.2; 0–2.7
Central arterial catheters (Swan-Ganz) ICU 3.6; 0–13.2
N/A, not applicable.
aIncludes umbilical and central lines
Data from the web page of Health Canada, Health Protection Branch, Laboratory Center for Disease Control; from Maki’s
meta-analysis presented at the 39th ICCAC, 1999, and from the NNIS system (US) (NNIS system web page, report issued in
December, 2000).
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external surface pathway is the most important
source of infection [18,19]. These five are:
1 Contamination of the catheter at the time of
insertion due to poor aseptic technique.
2 Migration of skin organisms along the catheter
external surface.
3 Contamination of the catheter hub from extrinsic
or endogenous sources passing through the cathe-
ter lumen.
4 Contaminated infusate.
5 Hematogenous seeding from a distant infection.
For short-term catheters, skin contamination is
the most likely mechanism of pathogenesis,
whereas for long-term catheters, hub contamina-
tion is more frequent.
Approximately 65% of CRI originate from the
skin flora, 30% from the contaminated hub and 5%
from other pathways [20–27]. This distribution
probably reflects duration of catheterization and
type of patient population studied [28].
A thrombin sheath covers the internal and exter-
nal surfaces of the catheter following insertion and
contains host-derived proteins, to which bacteria
adhere (e.g. Staphylococcus aureus). Microbial fac-
tors include biofilm formation [e.g. coagulase-
negative staphylococci (CNS), Pseudomonas spp.
and Candida spp.] and adhesion of pathogens to
catheter surfaces (e.g. CNS, S. aureus, Candida spp.)
[29–34].
Finally, the material from which the catheter is
made is important. Teflon or polyurethane cathe-
ters are associated with fewer infections than
catheters made of polyvinyl chloride or polyethy-
lene.
The etiology of CRI depends on the type of
catheter, its location and use. Globally considered,
the etiology of CRI is summarized in Tables 2
and 3.
Staphylococci are the most frequently isolated
pathogens in CRI [15,27,35–40], particularly CNS,
followed by enterococci, S. aureus and Candida
species [41,42]. Before 1986, S. aureus was the most
frequently reported pathogen (data from the NNIS
system, USA).
The distribution of pathogens, nevertheless, var-
ies with the type of patient, the underlying con-
dition, the type of catheter, the unit and the quality
of catheter care.
The proportion of CR-BSI caused by Gram-
negative bacilli is higher in children with cancer
(32–48%) [43,44], in AIDS patients and in patients
who have catheters with a jugular or femoral
insertion site [45].
Unusual pathogens, such as Enterobacter spp.
and nonfermenting Gram-negative rods, should
alert the clinician to check for possible contami-
nated arterial transducer systems, infusion pro-
ducts, or contaminated disinfectants if not
cultured from any other anatomical site [28]. Can-
dida spp., S. aureus and Malassezia furfur in neonatal
ICUs are more frequent in patients with total
parenteral nutrition [28].
D I A G N O S I S
Inflammatory signs show a poor correlation with
CRI, especially in CVC-related infections. Local
inflammatory signs at the catheter’s portal of entry
or tunnel have a highly predictive value for infec-
tion but its absence has a very poor negative value.
Therefore, microbiological techniques are neces-
sary to identify catheter colonization or infection.
The reference diagnostic techniques are based
on culture of the catheter tip after its removal.
However, only about 15–25% of CVC removed
because of a suspected infection actually prove
Table 2 Etiology of CRI
Micro-organism Percentage
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to be infected (this percentage rises to 70% for all
types of catheters in some series [46–49]), and the
diagnosis is always retrospective. This is the rea-
son why new diagnostic techniques that do not
require catheter withdrawal have been developed.
We will describe the most widespread diagnos-
tic techniques used, either non-conservative [39,
50–54] or conservative [21,55–59].
Non-conservative procedures to assess CRI
The most common techniques based on removal of
the catheter are: qualitative cultures, Maki’s semi-
quantitative culture, quantitative endoluminal
cultures after flushing the catheter and sonication.
The qualitative procedure is based on the cul-
ture of the catheter tip in a tube of broth to check
for sterility [50]. It is not in use nowadays due to its
lack of specificity (75%), despite its high sensitivity
(95%) [52,60,61].
Maki’s semiquantitative method [62] is still the
international reference diagnostic method, and it is
used as the standard in every study that evaluates
different diagnostic methods [28]. It consists of
rolling the distal 3–4 cm of the catheter (its tip)
back and forth on an agar plate. The threshold of
colony-forming units (c.f.u.) per plate is 15 (an
arbitrarily established threshold). Maki and col-
leagues have reported a specificity ranging
between 76 and 96% and a positive predictive
value for CR-BSI of 16–31% in four studies. The
positive predictive value for CR-BSI of this method
ranges from 8.8 to 72%, depending on the mean
placement time of the catheter and the prevalence
of associated sepsis [35,39,54,63]. Siegman-Ygra
et al. report an 85% sensitivity and an 85% speci-
ficity in a meta-analysis of the diagnosis of CR-BSI
[60]. Theoretically, it detects bacteria on the outer
surface of the catheter but this has not been firmly
established [64].
To avoid missing micro-organisms progressing
intraluminally, an endoluminal culturing system
was developed by Cleri et al. [53]. Quantitative
endoluminal cultures were obtained by flushing
the catheter tip with broth. The number of colony-
forming units was determined by serial dilution.
The authors defined an infected intravascular
insert as having >103 c.f.u.; this definition was
based on the finding that all inserts with an asso-
ciated bacteremia grew >103 c.f.u. of the organism
isolated from the blood. The procedure is cum-
bersome for routine use and was modified by
Brun-Buisson [52] who eluted bacteria into sterile
water for semiquantitative culture by vortexing
the catheter tip. A threshold for a significant count
was settled at 103 c.f.u./mL [52]. Lin˜ares et al.
compared the traditional semiquantitative method
with a quantitative technique performed by
means of flushing the catheter lumen with 2 mL
of trypticase soy broth, which was serially diluted
and cultured; they used the same criterion for
positivity (103 c.f.u./mL) [54]. This study
enabled the authors to demonstrate that hub colo-
nization was a primary source of CR-BSI (see
below).
In 1990 we reported a comparative study of
Maki’s technique with quantitative cultures after
vortexing the catheter tip in systematic use in a
clinical microbiology laboratory, and were unable
to show significant differences [21].
A method of quantitative culture after sonica-
tion was proposed by Sherertz in 1990 [39]. Com-
pared with semiquantitative cultures (roll plate
method), this method is 20% more sensitive for
the diagnosis of catheter infection, and>20% more
sensitive than the method of flushing the indivi-
dual catheter lumens [65]. Its disadvantages are
the additional equipment required and the diffi-
cult standardization of the ultrasound. In our
opinion, Maki’s semiquantitative technique is still
the reference procedure in most busy clinical
microbiology laboratories.
Conservative procedures to assess CRI
Intraluminal brushing of the catheter still in place
was proposed by Markus et al. in 1989 [55]. It has a
sensitivity of>90% and a specificity of 84% [64,66].
However, it turned out to be an impractical and
unreliable procedure in our experience (Bouza E,
ECCMID 1997), and important side-effects such as
cardiac arrhythmias, embolization, or subsequent
bacteremia have been reported. Therefore it is not
a method that can be recommended without
further study.
The hub has proved to be the main source of
bacterial entry for catheters in use for more than
10 days [23,54,56]; hub colonization is an indepen-
dent risk factor for CR-BSI [26,67]. Semiquantita-
tive ‘superficial cultures’ of the hub and of the skin
have a high sensitivity (from 80% to >90%) and a
high negative predictive value (97%) [21,68]. These
may prevent unnecessary catheter changes for
diagnostic purposes. Sensitivity can be improved
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by swabbing and culturing not only the skin at the
insertion site but also 1 cm of the subcutaneous
portion of the catheter, once it has been pulled
away to do so [69]. Besides, when skin superficial
cultures are performed in patients with a high
suspicion of CR-BSI, the positive predictive value
rises to almost 100% [70].
Based on the diagnosis of CRI by direct acridine
orange staining of catheter tips [57], Rusforth et al.
described a new technique in 1993 [71], which was
later validated by Kite et al. [72]. It comprises
preparing a cellular monolayer from a 50-mL blood
sample, obtained through the catheter. Thus, 100 mL
of blood are required to prepare two smears. The
smears are stained with acridine orange and exam-
ined under ultraviolet light. It has a sensitivity of
96% and a specificity of 92%, with positive and
negative predictive values of 91 and 97%, respec-
tively. By comparison, the tip-roll, tip-flush and
endoluminal-brush methods showed sensitivities
of 90, 95 and 92%, and specificities of 55, 76 and
98%, respectively [72]. This is a simple technique,
fast (30 min) and inexpensive. Others should vali-
date this technique before it is put to general use.
Differential quantitative blood cultures from
samples taken simultaneously from the catheter
and a peripheral vein are also used for the diag-
nosis of CR-BSI [58]. A central-to-peripheral blood
culture colony count ratio of 5 : 1–10 : 1 is consid-
ered indicative of CRI. Some authorities recom-
mend that blood samples for culture be obtained
from each lumen in multiple-lumen catheters.
Sensitivity of this method ranges from 79 to
>80% and specificity from 94 to 100% [60]. Sensi-
tivity is low (20–40%) in the absence of associated
bacteremia [63]. Its drawbacks are that it is a
cumbersome method and it requires the presence
of an easy backflow of blood in the catheter and the
existence of bacteremia.
Blot and Brun-Buisson have applied a recent
addition to this technique [59,73,74]: the time to
growth of cultures drawn through the catheter and
by venepuncture, or ‘differential time to positivity’
of paired samples. A cut-off value ofþ120 min was
established. This method shows a sensitivity of
94% and a specificity of 91% for CR-BSI diagnosis,
and can be proposed for routine clinical practice in
most hospitals using automatic devices for blood
cultures. Usually, hospitals do not have quantita-
tive blood culture methodologies, but many will
be able to use differential time to positivity for
diagnosis.
The best diagnostic method for implantable
device-associated BSI is paired quantitative blood
culturing [75,76]. Its sensitivity is almost 80%
and its specificity is close to 100%, with very
high positive and negative predictive values
[61]. Tip cultures after device removal showed
only a sensitivity of 46%, while membrane cultures
showed a sensitivity of 93%. Besides, paired quan-
titative blood cultures allow for diagnosis without
removal of the device suspected of infection.
T R E A T M E N T
Clinically the two milestones for the treatment of
CRI have been removal of the catheter and anti-
microbial therapy. Both aspects merit discussion.
Indications for catheter removal are summarized
in Table 4 [61,77–82].
In contrast, a salvage technique of the catheter
can be undertaken only if all conditions in Table 5
are fulfilled.
Regarding antimicrobial therapy, it can be
administered either on an empirical basis or after
a well-established microbiological diagnosis.
In our opinion, antimicrobial agents should be
administered on an empirical basis when any of
Table 4 Indications for catheter removal in CRI (the fulfilment of one or more of the following)
Easy to change catheter (e.g. short-term peripheral catheter with suspicion of infection)
Bacteremia/sepsis persisting >48–72 h
Presence of local complications (e.g. signs of tunnel or port infection)
Presence of metastatic complications (e.g. infective endocarditis, pulmonary embolism or peripheral embolism in arterial
catheters)
Micro-organisms difficult to eradicate (e.g. S. aureus, Bacillus spp., Corynebacterium spp., Pseudomonas spp., mycobacteria,
fungi)
Exchange of a CVC over the guidewire with significant colonization according to the results of quantitative or
semiquantitative cultures
Relapse of infection after antibiotics have been discontinued
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the conditions summarized in Table 6 are present
[61,80,83,84].
Considering the high rate of methicillin-resis-
tance in staphylococci currently in hospitals,
empirical antimicrobial therapy should include
the administration of an aminoglycoside with van-
comycin together with aztreonam or a third-gen-
eration cephalosporin if a Gram-negative rod is
suspected [61]. In neutropenic patients empirical
treatment should include drugs active against
Pseudomonas aeruginosa.
Etiologically guided therapy should be insti-
tuted as soon as possible, depending on the diag-
nostic method used. Adequacy of treatment is of
paramount importance as the administration of
inadequate antimicrobial treatment to critically
ill patients with BSI is associated with a greater
hospital mortality [85].
Initial antimicrobial therapy should be given
intravenously, but once the patient’s condition
has stabilized and antibiotic susceptibilities are
known, an oral quinolone, such as ciprofloxacin,
trimethoprim-sulfamethoxazole, rifampin, or line-
zolid could be administered because of their
excellent oral bioavailability and tissue penetra-
tion [61,86].
There are no compelling data to support specific
recommendations regarding the duration of ther-
apy for device-related infections.
Patients with catheter-related bacteremia
should be separated into two groups, those with
complicated infections, such as septic thrombosis,
endocarditis, osteomyelitis, or metastatic seeding,
and those with uncomplicated bacteremia, in
which such complications are not evident.
If there is a prompt response to initial antibiotic
therapy, most patients who are not immunocom-
promised, without underlying valvular heart dis-
ease or an intravascular prosthetic device, should
receive 10–14 days of antimicrobial therapy. This is
the generally accepted recommendation. In case of
CNS infection, antibiotic therapy may be shor-
tened to 5–7 days [61].
The duration of treatment for S. aureus CR-BSI is
controversial and depends on whether there are
associated complications; recommendations vary
from 2 to 6 weeks [61,79,82]. For other pathogens,
we refer the reader to the recently issued IDSA
guidelines on this subject [61].
Treatment also varies according to location of
the infection. It is important to remember that in
suppurative thrombophlebitis, surgical drainage,
ligation, or vein excision are occasionally indicated
when there is no resolution with antimicrobial
agents alone.
Difficult-to-replace CVC, subcutaneous reser-
voirs and implantable device-associated infections
have been successfully treated with the ‘antibiotic-
lock’ technique [87–89].
‘Antibiotic lock’ therapy for CR-BSI is often used
in conjunction with systemic antibiotic therapy
and involves instilling into the catheter lumen a
high concentration of an antibiotic to which the
causative pathogen is susceptible. Antibiotic solu-
tions that contain the desired antimicrobial agent
in a concentration of 1–5 mg/mL are usually
mixed with 50–100 U of heparin (or normal saline)
in sufficient volume to fill the catheter lumen
(usually 2–5 mL) and are instilled or ‘locked’ into
the catheter lumen during periods when the cathe-
ter is not being used (e.g. for a 12-h period each
night).
Several open trials of ‘antibiotic lock’ therapy of
tunneled catheter-related bacteremia, with or
without concomitant parenteral therapy, have
reported a response and catheter salvage without
relapse in 138 (82.6%) of 167 episodes [88–96].
Intraluminal therapy is attractive for a number
of reasons other than providing effective treat-
ment while allowing preservation of the cathe-
ter. These include: less toxic antibiotic-related
Table 6 Indications for empirical antimicrobial therapy in
patients with suspected CR-BSI
Always if the catheter is left in place
After removal if:
The catheter is a CVC
The patient has severe sepsis
The patient has suppurative thrombophlebitis
There are metastatic complications (e.g. lung or
peripheral embolism)
The patient is immunosuppressed
The patients has an endovascular prosthesis
Table 5 Conditions to try to salvage a catheter in a CRI (all
conditions required)
Indications for salvage of the catheter
Difficult-to-replace catheters
Blood sterile in 48–72 h
No signs of tunnel or port infection
No signs of metastatic complications
Micro-organisms medically treatable
Hemodynamically stable patient
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reactions, reduced development of resistance in
other micro-organisms of the patient’s flora, use-
fulness for home or outpatient administration and
the lowered costs of treatment are lower with the
administration of such small doses of antibiotics
[97].
This technique has also proved its efficacy in the
prevention of catheter colonization and CR-BSI
[98–101]. It has demonstrated its usefulness both
in infections by CNS and by other micro-organ-
isms. Still, some pathogens may be more difficult
to eradicate, e.g. fungi.
Because the purpose of ‘antibiotic lock’ therapy
is to sterilize the lumen of the catheter, patients
should be selected to receive such treatment
on the basis of a high likelihood of intraluminal
infection.
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